The patient enrollment completed on 27th Feb or before.
2 weeks treatment plus 2 weeks of follow up. Company was expecting topline results in 6 weeks - that comes to 10th April - with COVID this can go to end of April.
Based on phase 2 data, I expect these results to be as good.
The current market cap is $111 million - the NSAID market is really big - an effective NSAID better than Advil and no opioid effect will be a great addition to some BP product line - mainly JnJ.
I do not expec this to go to $1 Billion market cap but I think it can definitely go to $500 million - that is 4 to 5 bagger
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM